OmniStar Financial Group’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,537
Closed -$370K 132
2025
Q4
$370K Buy
1,537
+220
+17% +$56.3K 0.22% 85
2025
Q3
$361K Buy
1,317
+82
+7% +$22.4K 0.22% 96
2025
Q2
$319K Buy
1,235
+96
+8% +$22.9K 0.24% 97
2025
Q1
$256K Sell
1,139
-2,161
-65% -$504K 0.2% 105
2024
Q4
$755K Sell
3,300
-433
-12% -$104K 0.61% 52
2024
Q3
$912K Buy
+3,733
New +$834K 0.68% 38

Other funds holding RMD

OmniStar Financial Group's RMD Position: Q1 2026 in Review

OmniStar Financial Group sold out of ResMed (RMD) in Q1 2026, closing a stake of 1,537 shares — an estimated $370K sold.

OmniStar Financial Group first reported a position in RMD in Q3 2024 and held it in 6 quarters. The position peaked at $912K in Q3 2024. 941 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • OmniStar Financial Group reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
  • OmniStar Financial Group sold 1,537 ResMed shares in Q1 2026, an estimated $370K.
  • OmniStar Financial Group first reported a position in ResMed in Q3 2024 and held it in 6 quarters.
  • OmniStar Financial Group's ResMed position peaked at $912K in Q3 2024.
  • 941 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on OmniStar Financial Group's 13F filing for Q1 2026, filed 15 May 2026.